News and stories

At a glace Pharmalink Extracts collaborated with the Biotechnologies Group when they needed advanced extraction capability to unlock high-value marine oils.

The Biotechnologies Group now has regulatory approval to process marine products for human and animal consumption.

At a glance Premium Seas collaborated with Callaghan Innovation’s Biotechnologies Group to develop and scale a process for concentrating and drying a fucoidan-rich seaweed extract.

At a glance Alchemy Gisborne partnered with Callaghan Innovation to transform the way finger limes are processed and create new value from second-grade fruit.

At a glance Ārepa, a brain-food technology company, is developing a novel sarmentosin isolate from blackcurrant by-products.

At a glance Alpha Group partnered with the Biotechnologies Group to develop a novel submerged fermentation process for Ganoderma lingzhi (Reishi mushroom).

At a glance Hawke’s Bay-based Kabocha Innovation is transforming squash seed by-product into a high-protein powder for use in beverages, bars, and more.

Dr Kirill Lagutin, Dr Andrew Lewis and Thomas Austin from our Biotechnologies Group have put local oils to the test, comparing the quality and composition of NZ extra virgin olive oils to international offerings as part of a recent market surveillance study.

Brandon Capital has the funds, experience and expertise to support life science companies from proof-of-concept through to commercialisation.

Avasa’s arterial coupler makes microvascular surgery quicker and safer empowering surgeons to securely and efficiently link microvascular arteries in under 10 minutes.

Scentian Bio's biosensor technology, based on insect olfactory receptors combined with AI, has created a detection that is 1000x more sensitive than that of even the best beagle.

An Auckland startup that has developed dairy-identical proteins has teamed up with world-renowned ice-cream maker Gianpaolo Grazioli​ to put its innovation to the taste test.